Dickson Prize in Science Lecture - Aviv Regev
— 6:00pm
Location:
In Person - Registration Required
-
Simmons Auditorium, Tepper Building
Speaker:
AVIV REGEV
,
Head and Executive Vice President, Genentech Research and Early Development
https://www.gene.com/scientists/our-scientists/aviv-regev
Single-cell and spatial methods have enabled the construction of atlases of human cells. However, atlases cannot directly explain how cells operate or restore them to health. Mapping every genetic or therapeutic possibility in the lab is impossible, but with AI researchers can generalize, develop testable predictions, and iterate between experiment and model. This lecture focuses on developing cell atlases and building a “Lab in a Loop” to deliver biological insights and new potential therapies from target discovery to clinical development.
—
Dr. Aviv Regev is the head and executive vice president of Genentech Research and Early Development (gRED), where she oversees all aspects of the company's drug discovery and early development activities. She also served as a professor of biology at MIT and a member of the executive leadership teams of the Broad Institute of MIT and Harvard.
Dr. Regev was selected for this award because of her highly impactful contributions to computational methodologies and resources for biological discovery. Her work pioneered computational methods in single cell and spatial genomics, which are widely used in biomedical research. As a founder and co-chair of the international Human Cell Atlas (HCA) project, she is helping to build a complete compendium of human cell types to advance our understanding of disease mechanisms.
—
About the Lecture: Awarded annually since 1970, Carnegie Mellon University's Dickson Prize in Science recognizes substantial achievements or sustained progress in the fields of the natural sciences, engineering, computer science or mathematics.
REGISTER → by Monday, March 9
For More Information:
ULS@andrew.cmu.edu